AMARIN CORP PLC\UK Public Float
AMARIN CORP PLC\UK (AMRN) had Public Float of $334.70 million as of 2025-06-30, per its 10-K filed 2026-03-02.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2026-03-02
- 2025-06-30: Entity Public Float $334.70M.
- 2024-06-30: Entity Public Float $282.70M.
- 2023-06-30: Entity Public Float $484.70M.
- 2022-06-30: Entity Public Float $721.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $334.70M 10-K · filed 2026-03-02 |
| 2024-06-30 | $282.70M 10-K · filed 2025-03-12 |
| 2023-06-30 | $484.70M 10-K · filed 2024-02-29 |
| 2022-06-30 | $721.20M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $1.71B 10-K/A · filed 2022-05-02 |
| 2020-06-30 | $2.64B 10-K · filed 2021-02-25 |
| 2019-06-30 | $6.37B 10-K/A · filed 2020-04-29 |
| 2018-06-30 | $902.00M 10-K · filed 2019-02-27 |
| 2017-06-30 | $1.10B 10-K · filed 2018-02-27 |
| 2016-06-30 | $381.80M 10-K · filed 2017-03-01 |
| 2015-06-30 | $433.30M 10-K · filed 2016-02-25 |
| 2014-06-30 | $277.00M 10-K · filed 2015-03-03 |
| 2013-06-30 | $785.00M 10-K · filed 2014-02-27 |
| 2012-06-30 | $1.92B 10-K · filed 2013-02-28 |
| 2011-06-30 | $1.39B 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |